Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Flow Cytometry01:23

Flow Cytometry

13.0K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
13.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Establishing a New Stem Cell Crossmatch Assay to Assess the Impact of HLA-Specific Antibodies on CD34+ Stem Cells.

HLA·2026
Same author

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.

Blood·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

Cell reports·2026
Same author

Treatment-emergent coagulopathy during azacitidine/venetoclax induction in AML.

Blood neoplasia·2026
Same author

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.

bioRxiv : the preprint server for biology·2025
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

bioRxiv : the preprint server for biology·2025

相关实验视频

Updated: Jul 2, 2025

IP-FCM: Immunoprecipitation Detected by Flow Cytometry
12:17

IP-FCM: Immunoprecipitation Detected by Flow Cytometry

Published on: December 2, 2010

17.5K

预测单抗原珠测试的流动细胞计交叉匹配结果.

Patrick A Flynn1, Sebastian Fernando1,2, Judith E Worthington1

  • 1Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK.

International journal of immunogenetics
|February 20, 2024
PubMed
概括

这项研究开发了一种使用单抗原珠 (SAB) 平均光强度 (MFI) 预测流细胞计交叉匹配 (FCXM) 结果的算法. 该算法准确预测T细胞和B细胞交叉匹配结果,有助于评估免疫风险.

关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈他的兼容性与不兼容性.免疫遗传学 免疫遗传学移植 移植 移植 移植

更多相关视频

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies
10:23

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies

Published on: May 19, 2023

840
Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

1.6K

相关实验视频

Last Updated: Jul 2, 2025

IP-FCM: Immunoprecipitation Detected by Flow Cytometry
12:17

IP-FCM: Immunoprecipitation Detected by Flow Cytometry

Published on: December 2, 2010

17.5K
Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies
10:23

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies

Published on: May 19, 2023

840
Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

1.6K

科学领域:

  • 免疫学 免疫学 免疫学
  • 移植科学 移植科学
  • 临床化学 临床化学

背景情况:

  • 流细胞计交叉匹配 (FCXM) 对于评估移植兼容性至关重要.
  • 使用移植前抗体查预测FCXM结果可以优化资源配置.
  • 单抗原珠 (SAB) 试验提供了详细的人类白细胞抗原 (HLA) 抗体信息.

研究的目的:

  • 开发和验证基于SAB平均光强度 (MFI) 预测FCXM结果的算法.
  • 为了将SAB MFI水平与已建立的国家外部质量保证体系 (NEQAS) 交叉匹配结果相关联.
  • 建立T细胞和B细胞交叉匹配的预测模型.

主要方法:

  • 从NEQAS (2019-2023) 能力测试中对159个血清样本和40个HLA类型的外周血液样本进行了回顾性分析.
  • 使用LABScreen单抗原 (SAB) 的查和使用LABType SSO的HLA类型.
  • 通过结合HLA I类和/或II类MFI值来开发预测算法,并使用接收器运行特征分析进行验证.

主要成果:

  • 组合的HLA I类MFI>5000准确预测T细胞交叉匹配 (96%的灵敏度,100%的特异性).
  • 对于B细胞交叉匹配的预测,HLA类I + 类II MFI>11,000显示出高准确度 (97%的灵敏度,82%的特异性).
  • 针对B细胞预测的优化模型,特别是针对HLAII类敏感性,显示出高灵敏度和特异性.

结论:

  • SAB MFI 级别可以可靠地预测 FCXM 结果,特别是 T 细胞交叉匹配.
  • 开发的算法提供了一个有价值的工具,用于估计FCXM不可行时,来自供体特异性抗体的免疫风险.
  • 这种预测模型增强了移植前的风险评估和移植中的资源管理.